Lenskart Solutions Limited (NSE:LENSKART)
717.30
-1.50 (-0.21%)
Nov 11, 2026, 1:00 PM IST
Lenskart Solutions Revenue
Lenskart Solutions had revenue of 28.45B INR in the quarter ending September 30, 2026, with 35.73% growth. This brings the company's total for the last twelve months to 103.83B, up 40.55% year-over-year. In the fiscal year ending March 31, 2026, Lenskart Solutions had annual revenue of 88.14B with 32.49% growth. That makes Lenskart Solutions the 7,209th largest company in the world by revenue and 270th in India.
Revenue (ttm)
103.83B
Revenue Growth
+40.55%
P/S Ratio
11.91
Revenue / Employee
5.41M
Employees
19,201
Market Cap
1.25T
Revenue by Geography
- India 52.60B 59.3%
- International 36.06B 40.7%
Fiscal year ended Mar 31, 2026 See the full Lenskart Solutions breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 88.14B | 21.62B | 32.49% |
| Mar 31, 2025 | 66.53B | 12.25B | 22.57% |
| Mar 31, 2024 | 54.28B | 16.38B | 43.23% |
| Mar 31, 2023 | 37.89B | 22.87B | 152.17% |
| Mar 31, 2022 | 15.03B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Aurobindo Pharma | 369.13B |
| Zydus Lifesciences | 303.78B |
| Cipla | 279.89B |
| Apollo Hospitals Enterprise | 278.52B |
| Glenmark Pharmaceuticals | 159.97B |
| Mankind Pharma | 153.79B |
| Alkem Laboratories | 150.81B |
Lenskart Solutions News
- 6 days ago - Lenskart Solutions Transcript: Q2 26/27 - Transcripts
- 6 days ago - Lenskart Solutions Quarterly report: Q2 2027 - Filings
- 6 days ago - Lenskart Solutions Shareholder letter: Q2 2027 - Filings
- 6 days ago - Lenskart Solutions Slides: Q2 2027 - Filings
- 3 months ago - Lenskart Solutions Transcript: Q1 26/27 - Transcripts
- 3 months ago - Lenskart Solutions Quarterly report: Q1 2027 - Filings
- 3 months ago - Lenskart Solutions Shareholder letter: Q1 2027 - Filings
- 5 months ago - Lenskart Solutions Transcript: Q4 25/26 - Transcripts